Processa Pharmaceuticals (PCSA) Interest Coverage Ratio (2012 - 2025)
Processa Pharmaceuticals' (PCSA) quarterly Interest Coverage Ratio came in at 205660.5 in Q4 2025, down 21763.83% on a QoQ basis from 940.64 in Q3 2025.
Processa Pharmaceuticals (PCSA) Interest Coverage Ratio (2012 - 2025) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 14 years of Interest Coverage Ratio data on file, last reported at 205660.5 in Q4 2025.
- Quarterly Interest Coverage Ratio changed N/A year-over-year to 205660.5 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 69.55 (changed N/A YoY) and the FY2025 annual result came in at 0.66, down 8.33% from the prior year.
- Interest Coverage Ratio slipped to 205660.5 in Q4 2025, from 940.64 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.14 in Q4 2023 to a low of 205660.5 in Q4 2025.
- A 5-year average of 12595.34 and a median of 86.48 in 2022 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2021 — Interest Coverage Ratio plunged 112465.55% — and 2023, when it soared 99.18%.
- Tracing PCSA's Interest Coverage Ratio over 5 years: stood at 28.66 in 2021, then soared by 96.86% to 0.9 in 2022, then soared by 84.42% to 0.14 in 2023, then sank by 26095.76% to 36.67 in 2024, then sank by 560683.69% to 205660.5 in 2025.
- The last three Interest Coverage Ratio figures came in at 205660.5 (Q4 2025), 940.64 (Q3 2025), and 1007.85 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Processa Pharmaceuticals | 5.69 Mn | 5.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -205,660.50 |
| Sep 30, 2025 | -940.64 |
| Jun 30, 2025 | -1,007.85 |
| Sep 30, 2024 | -36.67 |
| Jun 30, 2024 | -292.41 |
| Mar 31, 2024 | -20.32 |
| Dec 31, 2023 | -0.14 |
| Sep 30, 2023 | -11.62 |
| Jun 30, 2023 | -12.94 |
| Mar 31, 2023 | -17.62 |
| Dec 31, 2022 | -0.90 |
| Sep 30, 2022 | -86.48 |
| Jun 30, 2022 | -1,579.16 |
| Mar 31, 2022 | -794.08 |
| Sep 30, 2021 | -28.66 |
| Jun 30, 2021 | -2,222.09 |
| Mar 31, 2021 | -1,408.68 |
| Dec 31, 2020 | -52.65 |
| Sep 30, 2020 | -15.87 |
| Jun 30, 2020 | -41.04 |